Specifically, Integrin acts as the anchor of cells to its adjacent matrix components, and Integrin/FAK as a signaling bridge to connect the tumor microenvironment and the cancer cells, which helps the deteriorated cells to acclimate the cancer-associated contexts. The gene discussed is PTK2; the disease is cancer.